Clinical Trial Update: Nilotinib With Chemotherapy for the Treatment of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update notes the termination of a Phase 1/2 study evaluating nilotinib in combination with chemotherapy for Philadelphia chromosome–positive…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Precursor B-cell Lymphoblastic Leukemia Lymphoma

Drugs mentioned

• Nilotinib (nilotinib)

Snippet

Sponsor: Rony Schaffel | Conditions: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Acute Lymphoblastic Leukemia | Phase 1, Phase 2 | Status: TERMINATED